For research use only. Not for therapeutic Use.
MG-262 is a reversible proteasome inhibitor with diverse biological activities[1][2][3].
| Catalog Number | M034274 |
| CAS Number | 179324-22-2 |
| Synonyms | [(1R)-3-methyl-1-[[(2S)-4-methyl-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]pentanoyl]amino]butyl]boronic acid |
| Molecular Formula | C25H42BN3O6 |
| Purity | ≥95% |
| InChI | InChI=1S/C25H42BN3O6/c1-16(2)12-20(24(31)29-22(26(33)34)14-18(5)6)27-23(30)21(13-17(3)4)28-25(32)35-15-19-10-8-7-9-11-19/h7-11,16-18,20-22,33-34H,12-15H2,1-6H3,(H,27,30)(H,28,32)(H,29,31)/t20-,21-,22-/m0/s1 |
| InChIKey | MWKOOGAFELWOCD-FKBYEOEOSA-N |
| SMILES | B(C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1)(O)O |
| Reference | [1]. Mezquita J, et al. Down-regulation of Flt-1 gene expression by the proteasome inhibitor MG262. J Cell Biochem. 2003 Aug 15;89(6):1138-47. |
